Psoriatic Arthritis News and Research

RSS
Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.
Hormone hepcidin identified as potential trigger for psoriasis

Hormone hepcidin identified as potential trigger for psoriasis

Risankizumab outperforms ustekinumab in treating moderate-to-severe Crohn’s disease

Risankizumab outperforms ustekinumab in treating moderate-to-severe Crohn’s disease

Understanding gluten's role in autoimmunity and inflammation

Understanding gluten's role in autoimmunity and inflammation

New study links psoriasis severity to skin microbiome dysbiosis

New study links psoriasis severity to skin microbiome dysbiosis

Study shows high burden of arthritis symptoms in patients people with psoriasis

Study shows high burden of arthritis symptoms in patients people with psoriasis

Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis

Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis

Low stress resilience in youth linked to higher psoriasis risk later

Low stress resilience in youth linked to higher psoriasis risk later

Study uncovers key biological pathways driving psoriasis inflammation

Study uncovers key biological pathways driving psoriasis inflammation

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

New insights into the exacerbation of psoriasis through specific genetic defects

New insights into the exacerbation of psoriasis through specific genetic defects

ANU scientists uncover gene mutation driving psoriasis and psoriatic arthritis

ANU scientists uncover gene mutation driving psoriasis and psoriatic arthritis

Pregnant women with autoimmune conditions at a greater risk of developing adverse pregnancy outcomes, study suggests

Pregnant women with autoimmune conditions at a greater risk of developing adverse pregnancy outcomes, study suggests

Is there a higher risk of depression among specific populations of patients with rheumatoid arthritis?

Is there a higher risk of depression among specific populations of patients with rheumatoid arthritis?

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

Study finds no fertility decline in men with inflammatory joint disease

Study finds no fertility decline in men with inflammatory joint disease

New treatment option for hand osteoarthritis identified

New treatment option for hand osteoarthritis identified

Researchers call for urgent improvement in pain management for inflammatory arthritis patients

Researchers call for urgent improvement in pain management for inflammatory arthritis patients

Is there an association between psoriasis onset and risk of autoimmune disease?

Is there an association between psoriasis onset and risk of autoimmune disease?

Study sheds light on potential mechanism by which psoriasis increases cardiovascular risk

Study sheds light on potential mechanism by which psoriasis increases cardiovascular risk

Multi-omics study offers insights into psoriasis treatment

Multi-omics study offers insights into psoriasis treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.